nigericin has been researched along with 2-((aminocarbonyl)amino)-5-(4-fluorophenyl)-3-thiophenecarboxamide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bodendorf, U; Boettcher, A; Bornancin, F; Eder, J; Erbel, P; Farady, CJ; Fruhauf, A; Heiser, D; Kauffmann, M; Rubert, J; Schlapbach, A; Unterreiner, A | 1 |
1 other study(ies) available for nigericin and 2-((aminocarbonyl)amino)-5-(4-fluorophenyl)-3-thiophenecarboxamide
Article | Year |
---|---|
Pharmacological inhibition of IKKβ dampens NLRP3 inflammasome activation after priming in the human myeloid cell line THP-1.
Topics: Amides; Caspase 1; Humans; I-kappa B Kinase; Immunity, Innate; Inflammasomes; Interleukin-1beta; NF-kappa B; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; Protein Kinase Inhibitors; Thiophenes; THP-1 Cells | 2021 |